Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)-Reference-Cited by-同舟云学术

Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)

Published:2023-10 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Weickhardt Andrew^ORCID,Foroudi Farshad,Lawrentschuk Nathan,Xie Jing,Sidhom Mark,Pal Abhijit,Grimison Peter,Zhang Alison,Ng Siobhan,Tang Colin,Hovey Elizabeth,Chen Colin,Hruby George,Guminski Alexander,McJannett Margaret,Conduit Ciara,Tran Ben,Davis Ian D.,Hayne Dickon

Funder

Merck Sharp & Dohme (Australia) Pty Limited

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference37 articles.

1. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer;James;N Engl J Med,2012

2. Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial;Hall;Eur Urol,2022

3. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis;Zlotta;Lancet Oncol,2023

4. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017

5. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma;Powles;N Engl J Med,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder sparing options for muscle-invasive bladder cancer;Current Opinion in Urology;2024-09-03

2. Organ preservation in muscle-invasive urothelial bladder cancer;Current Opinion in Oncology;2024-03-08